SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001640455-18-000059
Filing Date
2018-05-09
Accepted
2018-05-09 07:25:19
Documents
3
Period of Report
2018-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K jnce033120188-k.htm 8-K 25387
2 EXHIBIT 99.1 jnce03312018exhibit991.htm EX-99.1 69230
3 jouncelogosmaller.jpg GRAPHIC 44678
  Complete submission text file 0001640455-18-000059.txt   157163
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Filer) CIK: 0001640455 (see all company filings)

IRS No.: 454870634 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37998 | Film No.: 18816672
SIC: 2836 Biological Products, (No Diagnostic Substances)